BRPI0915173A2 - Nucleotídeos e nucleosídeos e métodos para uso dos mesmos em sequenciamento de dna - Google Patents

Nucleotídeos e nucleosídeos e métodos para uso dos mesmos em sequenciamento de dna

Info

Publication number
BRPI0915173A2
BRPI0915173A2 BRPI0915173-7A BRPI0915173A BRPI0915173A2 BR PI0915173 A2 BRPI0915173 A2 BR PI0915173A2 BR PI0915173 A BRPI0915173 A BR PI0915173A BR PI0915173 A2 BRPI0915173 A2 BR PI0915173A2
Authority
BR
Brazil
Prior art keywords
nucleosides
nucleotides
methods
dna sequencing
sequencing
Prior art date
Application number
BRPI0915173-7A
Other languages
English (en)
Inventor
Vladislav A Litosh
Megan N Hersh
Brian P Stupi
Weidong Wu
Michael L Metzker
Original Assignee
Lasergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lasergen Inc filed Critical Lasergen Inc
Publication of BRPI0915173A2 publication Critical patent/BRPI0915173A2/pt
Publication of BRPI0915173B1 publication Critical patent/BRPI0915173B1/pt
Publication of BRPI0915173B8 publication Critical patent/BRPI0915173B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/117—Modifications characterised by incorporating modified base
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
BRPI0915173A 2008-06-11 2009-06-11 compostos de nucleotídeos e nucleosídeos e método de sequenciamento de um ácido nucleico-alvo BRPI0915173B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6079508P 2008-06-11 2008-06-11
US61/060,795 2008-06-11
US18477909P 2009-06-05 2009-06-05
US61/184,779 2009-06-05
PCT/US2009/047071 WO2009152353A2 (en) 2008-06-11 2009-06-11 Nucleotides and nucleosides and methods for their use in dna sequencing

Publications (3)

Publication Number Publication Date
BRPI0915173A2 true BRPI0915173A2 (pt) 2015-08-18
BRPI0915173B1 BRPI0915173B1 (pt) 2021-05-04
BRPI0915173B8 BRPI0915173B8 (pt) 2021-05-25

Family

ID=41417396

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0915173A BRPI0915173B8 (pt) 2008-06-11 2009-06-11 compostos de nucleotídeos e nucleosídeos e método de sequenciamento de um ácido nucleico-alvo

Country Status (15)

Country Link
US (4) US8148503B2 (pt)
EP (1) EP2307565B1 (pt)
JP (1) JP5143953B2 (pt)
KR (1) KR101677772B1 (pt)
CN (2) CN102264917B (pt)
AU (1) AU2009257369B2 (pt)
BR (1) BRPI0915173B8 (pt)
CA (2) CA2727709C (pt)
EA (1) EA201100001A3 (pt)
HK (1) HK1163184A1 (pt)
IL (1) IL209917A (pt)
MX (1) MX2010013678A (pt)
NZ (2) NZ594812A (pt)
WO (1) WO2009152353A2 (pt)
ZA (1) ZA201100122B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897737B2 (en) 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
KR101677772B1 (ko) 2008-06-11 2016-11-18 레이저젠, 인코퍼레이티드 뉴클레오타이드 및 뉴클레오사이드 그리고 시퀀싱에서의 이들의 이용 방법
CN104328109A (zh) * 2008-09-22 2015-02-04 霍夫曼-拉罗奇有限公司 微阵列底物上的生物材料的选择性处理
CN103282518B (zh) * 2010-12-17 2016-11-16 纽约哥伦比亚大学理事会 使用经修饰的核苷酸和纳米孔检测的dna边合成边测序
EP3670523B1 (en) 2011-09-13 2021-08-11 Agilent Technologies, Inc. 3'-oh unblocked, fast photocleavable terminating nucleotides and their use in methods for nucleic acid sequencing
EP2850514A4 (en) * 2012-05-18 2016-03-02 Univ Georgetown METHOD AND SYSTEMS FOR FACILITATING AND SEARCHING A DATABASE OF INFORMATION ON MEDICINAL PRODUCTS
US9146248B2 (en) 2013-03-14 2015-09-29 Intelligent Bio-Systems, Inc. Apparatus and methods for purging flow cells in nucleic acid sequencing instruments
WO2014150851A1 (en) 2013-03-15 2014-09-25 Ibis Biosciences, Inc. Nucleotide analogs for sequencing
US9591268B2 (en) 2013-03-15 2017-03-07 Qiagen Waltham, Inc. Flow cell alignment methods and systems
EP2970365A4 (en) * 2013-03-15 2016-11-02 Ibis Biosciences Inc PHOTOCLELECTIVE DEOXYNUCLEOTIDES WITH HIGH RESOLUTION CONTROL OF DEPROTECTION KINETICS
SG11201608538UA (en) * 2014-04-29 2016-11-29 Biosearch Technologies Inc Compounds compositions and methods including thermally labile moieties
US10487357B2 (en) 2014-10-03 2019-11-26 Life Technologies Corporation Methods of nucleic acid analysis using terminator nucleotides
US10544455B2 (en) 2014-10-03 2020-01-28 Life Technologies Corporation Sequencing methods, compositions and systems using terminator nucleotides
WO2016065142A2 (en) 2014-10-22 2016-04-28 The Johns Hopkins University New scaffolds and multifunctional intermediates for imaging psma and cancer therapy
WO2016094845A2 (en) 2014-12-12 2016-06-16 Woolf Tod M Compositions and methods for editing nucleic acids in cells utilizing oligonucleotides
BR112018002525A2 (pt) 2015-08-06 2018-09-25 Lasergen Inc detecção de antígenos usando marcadores fotocliváveis
CN108603227A (zh) 2015-11-18 2018-09-28 卡利姆·U·米尔 超分辨率测序
CA3026193A1 (en) 2016-06-06 2017-12-14 Redvault Biosciences, Lp Target reporter constructs and uses thereof
US11371087B2 (en) * 2016-06-10 2022-06-28 Takara Bio Usa, Inc. Methods and compositions employing blocked primers
GB2559117B (en) * 2017-01-19 2019-11-27 Oxford Nanopore Tech Ltd Double stranded polynucleotide synthesis method, kit and system
CN108752406A (zh) * 2018-05-29 2018-11-06 苏州百源基因技术有限公司 一种荧光标记的核苷酸及其制备方法和用途
AU2020206999A1 (en) 2019-01-07 2021-07-29 Agilent Technologies, Inc. Compositions and methods for genomic dna and gene expression analysis in single cells
EP4127229A4 (en) * 2020-03-26 2024-04-17 Agilent Technologies Inc METHODS AND COMPOSITIONS FOR MULTI-STEP PRIMER EXTENSION REACTIONS
CN113341058A (zh) * 2021-06-09 2021-09-03 南京溯远基因科技有限公司 一种三色高通量测序试剂及测序方法
IL309368A (en) 2021-06-29 2024-02-01 Agilent Technologies Inc polymerase mutants and use with 3'-OH UNBLOCKED REVERSIBLE TERMINATORS
CN117858885A (zh) * 2021-07-05 2024-04-09 国立研究开发法人科学技术振兴机构 核苷酸类的纯化方法和核苷酸类的纯化装置以及疏水性试剂和疏水性底物

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2136624A1 (de) 1971-07-22 1973-02-08 Boehringer Mannheim Gmbh N (6)-substituierte adenosin-derivate und verfahren zur herstellung derselben
US4318846A (en) 1979-09-07 1982-03-09 Syva Company Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers
US4439356A (en) 1981-03-03 1984-03-27 Syva Company Unsymmetrical fluorescein derivatives
DE3406533A1 (de) 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
US4657897A (en) 1984-06-22 1987-04-14 Warner-Lambert Company N6 -substituted adenosines for treating pain
US5151507A (en) 1986-07-02 1992-09-29 E. I. Du Pont De Nemours And Company Alkynylamino-nucleotides
JP2527340B2 (ja) 1986-12-15 1996-08-21 アプライド バイオシステムズ インコーポレイテッド ロ―ダミン染料の５−及び６−スクシニミジルカルボキシレ―ト異性体
USRE38416E1 (en) 1988-09-28 2004-02-03 Epoch Biosciences, Inc. Cross-linking oligonucleotides
US5824796A (en) 1988-09-28 1998-10-20 Epoch Pharmaceuticals, Inc. Cross-linking oligonucleotides
US5302509A (en) 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
US5366860A (en) 1989-09-29 1994-11-22 Applied Biosystems, Inc. Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
US5188934A (en) 1989-11-14 1993-02-23 Applied Biosystems, Inc. 4,7-dichlorofluorescein dyes as molecular probes
GB9208733D0 (en) 1992-04-22 1992-06-10 Medical Res Council Dna sequencing method
AU7331094A (en) 1993-07-13 1995-02-13 United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The A3 adenosine receptor agonists
GB9315847D0 (en) 1993-07-30 1993-09-15 Isis Innovation Tag reagent and assay method
US5872244A (en) 1994-09-02 1999-02-16 Andrew C. Hiatt 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds
US5763594A (en) 1994-09-02 1998-06-09 Andrew C. Hiatt 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds
US5808045A (en) 1994-09-02 1998-09-15 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides
US6214987B1 (en) 1994-09-02 2001-04-10 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent formation of phosphodiester bonds using protected nucleotides
US5684142A (en) 1995-06-07 1997-11-04 Oncor, Inc. Modified nucleotides for nucleic acid labeling
US5614386A (en) 1995-06-23 1997-03-25 Baylor College Of Medicine Alternative dye-labeled primers for automated DNA sequencing
AU699939B2 (en) 1995-06-23 1998-12-17 Baylor College Of Medicine Alternative dye-labeled primers, ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis and homogeneous amplification/detection assays
US5994063A (en) 1995-06-23 1999-11-30 Metzker; Michael L. Substituted 4,4-difluoro-4-bora-3A,4A-diaza-s-indacene compounds for homogenous amplification/detection assays
US5728529A (en) 1995-06-23 1998-03-17 Baylor College Of Medicine Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis
US5861287A (en) 1995-06-23 1999-01-19 Baylor College Of Medicine Alternative dye-labeled primers for automated DNA sequencing
DK0866071T3 (da) 1997-03-20 2005-01-17 Hoffmann La Roche Modificerede primere
EP0991414A4 (en) 1997-05-09 2002-10-02 Univ Pennsylvania METHODS FOR REDUCING CARDIAC ISCHEMIC LESION BY ADMINISTRATION OF ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS AND RELATED COMPOSITIONS
US6232103B1 (en) * 1998-03-23 2001-05-15 Invitrogen Corporation Methods useful for nucleic acid sequencing using modified nucleotides comprising phenylboronic acid
CA2347512C (en) * 1998-10-16 2005-12-06 Pfizer Inc. Adenine derivatives
DE69930310T3 (de) 1998-12-14 2009-12-17 Pacific Biosciences of California, Inc. (n. d. Ges. d. Staates Delaware), Menlo Park Kit und methode zur nukleinsäuresequenzierung einzelner moleküle durch polymerase synthese
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
EP1218543A2 (en) 1999-09-29 2002-07-03 Solexa Ltd. Polynucleotide sequencing
US6586413B2 (en) 1999-11-05 2003-07-01 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
EA200601591A1 (ru) 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
US6869764B2 (en) 2000-06-07 2005-03-22 L--Cor, Inc. Nucleic acid sequencing using charge-switch nucleotides
MY141594A (en) 2000-06-15 2010-05-14 Novirio Pharmaceuticals Ltd 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
US6875751B2 (en) 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
GB0015727D0 (en) * 2000-06-27 2000-08-16 Pfizer Ltd Purine derivatives
WO2002004680A2 (en) 2000-07-07 2002-01-17 Visigen Biotechnologies, Inc. Real-time sequence determination
US7125660B2 (en) 2000-09-13 2006-10-24 Archemix Corp. Nucleic acid sensor molecules and methods of using same
WO2002029003A2 (en) 2000-10-06 2002-04-11 The Trustees Of Columbia University In The City Of New York Massive parallel method for decoding dna and rna
DE60230689D1 (de) 2001-04-10 2009-02-12 Ecole Polytech Verfahren zur Verwendung von O6-Alkylguanin-DNS Alkyltransferasen
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
WO2003004510A1 (de) 2001-07-03 2003-01-16 Febit Ag Zweistufige schutzgruppen für die synthese von biopolymeren
US6995841B2 (en) 2001-08-28 2006-02-07 Rice University Pulsed-multiline excitation for color-blind fluorescence detection
GB0128526D0 (en) 2001-11-29 2002-01-23 Amersham Pharm Biotech Uk Ltd Nucleotide analogues
US7057026B2 (en) 2001-12-04 2006-06-06 Solexa Limited Labelled nucleotides
AU2003244370A1 (en) 2002-02-05 2003-09-02 Baylor College Of Medecine Substituted 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene compounds for 8-color dna sequencing
AU2003224836A1 (en) 2002-04-12 2003-10-27 Stratagene Dual-labeled nucleotides
EP3795577A1 (en) 2002-08-23 2021-03-24 Illumina Cambridge Limited Modified nucleotides
EP1560838B1 (en) 2002-08-23 2009-05-13 Illumina Cambridge Limited Labelled nucleotides
US7414116B2 (en) 2002-08-23 2008-08-19 Illumina Cambridge Limited Labelled nucleotides
CZ294538B6 (cs) 2002-12-30 2005-01-12 Ústav Experimentální Botaniky Akademie Vědčeské Re Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
US7427679B2 (en) 2003-08-30 2008-09-23 Agilent Technologies, Inc. Precursors for two-step polynucleotide synthesis
US7193077B2 (en) 2003-08-30 2007-03-20 Agilent Technologies, Inc. Exocyclic amine triaryl methyl protecting groups in two-step polynucleotide synthesis
US7417139B2 (en) 2003-08-30 2008-08-26 Agilent Technologies, Inc. Method for polynucleotide synthesis
US8637650B2 (en) 2003-11-05 2014-01-28 Genovoxx Gmbh Macromolecular nucleotide compounds and methods for using the same
WO2005084367A2 (en) 2004-03-03 2005-09-15 The Trustees Of Columbia University In The City Of New York Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry
US7476734B2 (en) 2005-12-06 2009-01-13 Helicos Biosciences Corporation Nucleotide analogs
WO2006084281A1 (en) * 2005-02-04 2006-08-10 Millennium Pharmaceuticals, Inc. Inhibitors of e1 activating enzymes
GB0517097D0 (en) 2005-08-19 2005-09-28 Solexa Ltd Modified nucleosides and nucleotides and uses thereof
BRPI0719923B1 (pt) * 2006-12-05 2021-08-17 Agilent Technologies Inc Métodos para sequenciamento de um ácido nucléico alvo, para conversão de um componente de ocorrência não natural em uma molécula de ácido nucléico em um componente de ocorrência natural, para terminar uma síntese de ácido nucléico, e para realizar o sequenciamento de sanger ou tipo sanger, e compostos
US7897737B2 (en) * 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
US7893227B2 (en) 2006-12-05 2011-02-22 Lasergen, Inc. 3′-OH unblocked nucleotides and nucleosides base modified with non-cleavable, terminating groups and methods for their use in DNA sequencing
KR101677772B1 (ko) 2008-06-11 2016-11-18 레이저젠, 인코퍼레이티드 뉴클레오타이드 및 뉴클레오사이드 그리고 시퀀싱에서의 이들의 이용 방법

Also Published As

Publication number Publication date
EA201100001A3 (ru) 2013-03-29
WO2009152353A2 (en) 2009-12-17
NZ590265A (en) 2012-11-30
US20100041041A1 (en) 2010-02-18
US20140051848A1 (en) 2014-02-20
AU2009257369A1 (en) 2009-12-17
US9200319B2 (en) 2015-12-01
EP2307565A2 (en) 2011-04-13
CA2727709A1 (en) 2009-12-17
IL209917A (en) 2014-06-30
US20150140559A1 (en) 2015-05-21
CN103588839A (zh) 2014-02-19
CN103588839B (zh) 2017-04-12
EA201100001A2 (ru) 2012-10-30
CA2979146C (en) 2020-07-07
MX2010013678A (es) 2011-02-24
US8877905B2 (en) 2014-11-04
IL209917A0 (en) 2011-02-28
HK1163184A1 (en) 2012-09-07
KR101677772B1 (ko) 2016-11-18
NZ594812A (en) 2012-12-21
JP5143953B2 (ja) 2013-02-13
AU2009257369B2 (en) 2015-03-26
BRPI0915173B1 (pt) 2021-05-04
US20130035237A1 (en) 2013-02-07
ZA201100122B (en) 2013-09-25
CA2727709C (en) 2017-11-14
WO2009152353A3 (en) 2013-09-26
JP2011529449A (ja) 2011-12-08
US8497360B2 (en) 2013-07-30
US8148503B2 (en) 2012-04-03
CN102264917A (zh) 2011-11-30
CN102264917B (zh) 2015-06-10
EP2307565B1 (en) 2017-11-29
CA2979146A1 (en) 2009-12-17
KR20110031191A (ko) 2011-03-24
BRPI0915173B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
BRPI0915173A2 (pt) Nucleotídeos e nucleosídeos e métodos para uso dos mesmos em sequenciamento de dna
ZA200903888B (en) Photocleavable labeled nucleotides and nucleosides and labeled nucleotides and nucleosides and methods for their use in DNA sequencing
BRPI0719923A2 (pt) Nucleotídeos e nucleosídeos rotulados fotocliváveis e nucleotídeos e nucleosídeos rotulados e métodos para seu uso no sequenciamento de dna
BRPI0916630A2 (pt) composições para uso em construção e processo de aplicação das mesmas
BRPI0914007A2 (pt) anatagonistas e agentes de ligação de notch e métodos para uso dos mesmos
BRPI0916059A2 (pt) emulsão de cera para uso em produtos de construção
BRPI0812233A2 (pt) Métodos e dispositivo para substituição exata de dna alvo em organismos eucarióticos.
BRPI0909212A2 (pt) Composições e método para sequeciamento de ácido nucléico
DK3682905T3 (da) Modificerede nukleosider, nukleotider og nukleinsyrer og anvendelser deraf
BRPI0821924A2 (pt) Moléculas de ligação baseadas em fibronectina melhoradas e seu uso
GB201014134D0 (en) Methods of RNA aplification in the presence of DNA
EP2173872A4 (en) COPY DNA AND SENSE RNA
BRPI0815725A2 (pt) Métodos para detecção de oligonucleotídeos
ZA201003235B (en) Use of oligonucleotides with modified bases in hybridization of nucleic acids
BRPI0918694A2 (pt) processo de detecção de coliforme e kit para uso do mesmo
EP1999276A4 (en) METHOD AND AGENT FOR NUCLEIC ACID SEQUENCING
BRPI0818963A2 (pt) Conjugado anticorpo-molécula parceira e método para tratar câncer em um indivíduo
BRPI0806902A2 (pt) MÉTODOS E COMPOSIÇÕES PARA MODULAÇÃO DAS VIAS DE METILAÇÃO DE DNA DIRECIONADA POR sIRNA E RNA
EP2126072A4 (en) MATERIALS AND METHOD FOR THE INDIVIDUAL MOLECULE SEQUENCING OF NUCLEIC ACIDS
BRPI0922786A2 (pt) sistemas de âncora-em-âncora para uso em fixação de osso
ZA201102252B (en) Methods and kits for nucleic acid sequencing
EP2622064A4 (en) NUCLEOSIDES, NUCLEOTIDES AND MODIFIED NUCLEIC ACIDS AND USES THEREOF
EP2059614A4 (en) ANTISONDON PROBE COMPOSITIONS AND METHODS OF DETECTION OF DNA OR RNA
BRPI0922355A2 (pt) ácidos nucléicos, métodos para reduzir a expressão de um gene em uma célula in vitro, uso de um ácido nucléico, complexo de rna e uso do complexo de rna
BRPI0820070A2 (pt) eletrodo frontal para uso em dispositivo fotovoltaico e método de fabricação do mesmo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: AGILENT TECHNOLOGIES INC. (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/06/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/06/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF